Eriksson, Jan W <br/><br/>
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Dec 2008 
 - 1030-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/HYPERTENSIONAHA.108.119404  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antihypertensive Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Biphenyl Compounds<br/>Blood Pressure--drug effects<br/>Body Composition<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--chemically induced<br/>Diuretics--administration & dosage<br/>Fatty Liver--chemically induced<br/>Female<br/>Glucose Clamp Technique<br/>Glucose Tolerance Test<br/>Humans<br/>Hydrochlorothiazide--administration & dosage<br/>Hyperinsulinism<br/>Hypertension--drug therapy<br/>Insulin Resistance<br/>Intra-Abdominal Fat--drug effects<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Muscle, Skeletal--pathology<br/>Tetrazoles--administration & dosage